- Previous Close
454.02 - Open
453.22 - Bid 435.75 x 100
- Ask 436.69 x 100
- Day's Range
436.20 - 457.07 - 52 Week Range
254.85 - 468.78 - Volume
1,797,119 - Avg. Volume
1,425,336 - Market Cap (intraday)
161.359B - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
78.13 - EPS (TTM)
5.59 - Earnings Date Oct 17, 2024 - Oct 21, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
468.85
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
www.intuitive.com13,676
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ISRG
View MoreRelated Videos: ISRG
Performance Overview: ISRG
Trailing total returns as of 7/25/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ISRG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ISRG
View MoreValuation Measures
Market Cap
161.36B
Enterprise Value
156.60B
Trailing P/E
78.02
Forward P/E
72.46
PEG Ratio (5yr expected)
4.71
Price/Sales (ttm)
21.56
Price/Book (mrq)
10.97
Enterprise Value/Revenue
20.68
Enterprise Value/EBITDA
65.10
Financial Highlights
Profitability and Income Statement
Profit Margin
27.65%
Return on Assets (ttm)
7.99%
Return on Equity (ttm)
15.77%
Revenue (ttm)
7.57B
Net Income Avi to Common (ttm)
2.09B
Diluted EPS (ttm)
5.59
Balance Sheet and Cash Flow
Total Cash (mrq)
4.76B
Total Debt/Equity (mrq)
1.91%
Levered Free Cash Flow (ttm)
372.34M
Research Analysis: ISRG
View MoreCompany Insights: ISRG
ISRG does not have Company Insights
Research Reports: ISRG
View MoreRaising target and EPS estimates
Intuitive Surgical designs, manufactures, and markets da Vinci robotic surgical systems and related instruments and accessories in the U.S. and internationally. The da Vinci system enables surgeons to perform a wide range of surgical procedures with shorter recovery periods and higher patient comfort. ISRG was founded in 1995 and is headquartered in Sunnyvale, California.
RatingPrice TargetEarnings news is the big driver today. All the action is mostly in individual
Earnings news is the big driver today. All the action is mostly in individual stocks reacting to whether last quarter was positive or negative, plus any intel on outlook. The major indices are muted though small caps are showing momentum higher.
Intuitive Earnings: Procedure Growth in the US Continues to Impress
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
RatingPrice TargetIntuitive Earnings: Results in Line; Placements of New Platform Commence
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
RatingPrice Target